Candel Therapeutics (CADL)

• Market cap: $342M
• 1 day: -6.22%
• 5 days: -2.51%
• 1 month: -17.78%
• 3 months: -19.06%
• 6 months: -3.71%
• Year to date: -14.15%
• 1 year: -41.18%
• 5 years: -33.29%
• 10 years: -33.29%
• Sector: Healthcare
• Industry: Biotechnology

About: Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Employees: 38